Clinical Trials · NCT04025372
INTREPId (INTermediate Risk Erection PreservatIon Trial)
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 234
- Start date
- Jun 2020
- Locations
- 11 sites, United States
- Primary endpoint
- The percentage of patients with a PSA nadir <= 0.5